StockData
LMRINasdaqServices-Medical LaboratoriesFiscal year ends December 31

Lumexa Imaging Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$10.72−0.06 (-0.56%)

Close on Oct 19, 2026

Market cap
$1.03B
P/E (TTM)
–
Dividend yield
–

Lumexa Imaging statistics

Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Medical Laboratories companies for comparison

Valuation

MeasureLumexa ImagingIndustry median
Market Cap$1.03B$1.11B
Enterprise Value$1.79B$1.41B
PB Ratio1.673.03

Balance sheet

MeasureLumexa ImagingIndustry median
Cash & Short-Term Investments$69.71M$48.71M
Total Debt$834.08M$140.00M
Net Cash (Debt)-$764.38M$205.49K
Net Cash Per Share-$7.96$0.01
Equity (Book Value)$615.06M$235.16M
Book Value Per Share$6.40$3.48
Tangible Book Value-$232.22M$703.69K
Working Capital$78.06M$30.48M

Financial position

MeasureLumexa ImagingIndustry median
Current Ratio1.441.40
Quick Ratio0.391.02
Debt / Equity1.360.66

Shares

MeasureLumexa ImagingIndustry median
Shares Outstanding96,075,00058,282,400
Shares Change (QoQ)-0.01%0.32%
Float25,331,30033,780,100
Shares Held by Insiders73.6%16.4%
Shares Held by Institutions32.7%85.9%

Scores

MeasureLumexa ImagingIndustry median
Altman Z-Score0.082.05

Calculated by StockData from Lumexa Imaging's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.